Report an error

Spotted something inaccurate in “Semaglutide Reduces Heart Events by 21-26% in SELECT Trial Subgroup with High-Risk Liver Fibrosis”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.